Drugs
FDA Accepts Wearable Sensor-Based Foot Drop Measure for Trials
FDA has accepted a letter of intent (LOI) for a wearable sensor-based digital outcome measure designed to assess foot drop severity and gait impairment in patients with Charcot-Marie-Tooth disease type 1A (CMT1A), marking the first digital health technology for a rare neurological condition accepted into the agency&